- Home
- FUFUW vs BEATW Comparison
FUFUW vs BEATW Comparison
Compare FUFUW & BEATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUFUW
- BEATW
- Stock Information
- Founded
- FUFUW N/A
- BEATW 2015
- Country
- FUFUW Singapore
- BEATW United States
- Employees
- FUFUW N/A
- BEATW 20
- Industry
- FUFUW
- BEATW Retail: Computer Software & Peripheral Equipment
- Sector
- FUFUW
- BEATW Technology
- Exchange
- FUFUW Nasdaq
- BEATW Nasdaq
- Market Cap
- FUFUW N/A
- BEATW N/A
- IPO Year
- FUFUW N/A
- BEATW N/A
- Fundamental
- Price
- FUFUW $0.43
- BEATW $0.56
- Analyst Decision
- FUFUW
- BEATW
- Analyst Count
- FUFUW 0
- BEATW 0
- Target Price
- FUFUW N/A
- BEATW N/A
- AVG Volume (30 Days)
- FUFUW 5.6K
- BEATW 4.7K
- Earning Date
- FUFUW 04-11-2025
- BEATW 03-14-2025
- Dividend Yield
- FUFUW N/A
- BEATW N/A
- EPS Growth
- FUFUW 1042.93
- BEATW N/A
- EPS
- FUFUW 0.23
- BEATW N/A
- Revenue
- FUFUW $452,743,012.00
- BEATW N/A
- Revenue This Year
- FUFUW N/A
- BEATW N/A
- Revenue Next Year
- FUFUW N/A
- BEATW N/A
- P/E Ratio
- FUFUW $22.02
- BEATW N/A
- Revenue Growth
- FUFUW 78.43
- BEATW N/A
- 52 Week Low
- FUFUW $0.46
- BEATW $0.50
- 52 Week High
- FUFUW $0.54
- BEATW $0.62
- Technical
- Relative Strength Index (RSI)
- FUFUW N/A
- BEATW N/A
- Support Level
- FUFUW N/A
- BEATW N/A
- Resistance Level
- FUFUW N/A
- BEATW N/A
- Average True Range (ATR)
- FUFUW 0.00
- BEATW 0.00
- MACD
- FUFUW 0.00
- BEATW 0.00
- Stochastic Oscillator
- FUFUW 0.00
- BEATW 0.00
About FUFUW BitFuFu Inc.
BitFuFu Inc is a digital asset mining and cloud-mining service provider that fosters a secure, compliant, and transparent blockchain infrastructure. It provides stable and intelligent digital asset mining solutions, including one-stop cloud-mining services and miner hosting services to institutional customers and individual digital assets.
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.